FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134934351> ?p ?o ?g. }

• W2134934351 endingPage "70" @default.
• W2134934351 startingPage "65" @default.
• W2134934351 abstract "Background Repetitive transcranial magnetic stimulation (rTMS) of the temporal cortex has shown beneficial effects in patients with chronic tinnitus. Recent preclinical data in healthy controls suggest that the effects of low-frequency rTMS can be enhanced by dopaminergic drugs. Objective We investigated whether application of the dopamine reuptake inhibitor bupropion increases the clinical effects of low-frequency rTMS over the auditory cortex in tinnitus patients. Subjects and Methods Eighteen subjects with chronic tinnitus received 10 sessions of 1 Hz rTMS (2000 pulses/day, 110% motor threshold) applied to the left temporal cortex. In addition, these subjects received one dosage of 150 mg bupropion (Wellbutrin XL/Elontril) 4 hours before each TMS session. Treatment outcome was assessed with a tinnitus questionnaire over a 3-month period. Treatment effects were compared with a control group of 100 tinnitus patients matched for age, tinnitus duration, and tinnitus questionnaire baseline scores, who received the same rTMS treatment without prior bupropion application. Results For the whole sample, there was a significant effect of rTMS treatment over time. There were no significant differences between the bupropion and the control group. Conclusions Our data suggest that 150 mg bupropion administration does not enhance the effect of rTMS in the treatment of tinnitus. Repetitive transcranial magnetic stimulation (rTMS) of the temporal cortex has shown beneficial effects in patients with chronic tinnitus. Recent preclinical data in healthy controls suggest that the effects of low-frequency rTMS can be enhanced by dopaminergic drugs. We investigated whether application of the dopamine reuptake inhibitor bupropion increases the clinical effects of low-frequency rTMS over the auditory cortex in tinnitus patients. Eighteen subjects with chronic tinnitus received 10 sessions of 1 Hz rTMS (2000 pulses/day, 110% motor threshold) applied to the left temporal cortex. In addition, these subjects received one dosage of 150 mg bupropion (Wellbutrin XL/Elontril) 4 hours before each TMS session. Treatment outcome was assessed with a tinnitus questionnaire over a 3-month period. Treatment effects were compared with a control group of 100 tinnitus patients matched for age, tinnitus duration, and tinnitus questionnaire baseline scores, who received the same rTMS treatment without prior bupropion application. For the whole sample, there was a significant effect of rTMS treatment over time. There were no significant differences between the bupropion and the control group. Our data suggest that 150 mg bupropion administration does not enhance the effect of rTMS in the treatment of tinnitus." @default.
• W2134934351 created "2016-06-24" @default.
• W2134934351 creator A5005180091 @default.
• W2134934351 creator A5018159030 @default.
• W2134934351 creator A5020699194 @default.
• W2134934351 creator A5045722599 @default.
• W2134934351 creator A5064104774 @default.
• W2134934351 creator A5071697628 @default.
• W2134934351 creator A5081124890 @default.
• W2134934351 creator A5085986301 @default.
• W2134934351 creator A5087164515 @default.
• W2134934351 date "2011-04-01" @default.
• W2134934351 modified "2023-09-24" @default.
• W2134934351 title "Repetitive transcranial magnetic stimulation for tinnitus treatment: No enhancement by the dopamine and noradrenaline reuptake inhibitor bupropion" @default.
• W2134934351 cites W1520463686 @default.
• W2134934351 cites W1553093690 @default.
• W2134934351 cites W1585668905 @default.
• W2134934351 cites W1592304224 @default.
• W2134934351 cites W1925107652 @default.
• W2134934351 cites W1976649820 @default.
• W2134934351 cites W1981157865 @default.
• W2134934351 cites W1992009432 @default.
• W2134934351 cites W1995055754 @default.
• W2134934351 cites W1997529240 @default.
• W2134934351 cites W2001182593 @default.
• W2134934351 cites W2003699689 @default.
• W2134934351 cites W2007528040 @default.
• W2134934351 cites W2011241648 @default.
• W2134934351 cites W2013272034 @default.
• W2134934351 cites W2018972291 @default.
• W2134934351 cites W2019148392 @default.
• W2134934351 cites W2026046957 @default.
• W2134934351 cites W2029174854 @default.
• W2134934351 cites W2032086532 @default.
• W2134934351 cites W2034961499 @default.
• W2134934351 cites W2044565695 @default.
• W2134934351 cites W2047048146 @default.
• W2134934351 cites W2062030875 @default.
• W2134934351 cites W2062103870 @default.
• W2134934351 cites W2074369546 @default.
• W2134934351 cites W2075988072 @default.
• W2134934351 cites W2076737508 @default.
• W2134934351 cites W2096967405 @default.
• W2134934351 cites W2115714588 @default.
• W2134934351 cites W2122098240 @default.
• W2134934351 cites W2124254123 @default.
• W2134934351 cites W2127102211 @default.
• W2134934351 cites W2129212500 @default.
• W2134934351 cites W2129234188 @default.
• W2134934351 cites W2130651137 @default.
• W2134934351 cites W2163736797 @default.
• W2134934351 cites W2170170290 @default.
• W2134934351 doi "https://doi.org/10.1016/j.brs.2010.03.007" @default.
• W2134934351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21511205" @default.
• W2134934351 hasPublicationYear "2011" @default.
• W2134934351 type Work @default.
• W2134934351 sameAs 2134934351 @default.
• W2134934351 citedByCount "17" @default.
• W2134934351 countsByYear W21349343512012 @default.
• W2134934351 countsByYear W21349343512013 @default.
• W2134934351 countsByYear W21349343512014 @default.
• W2134934351 countsByYear W21349343512015 @default.
• W2134934351 countsByYear W21349343512016 @default.
• W2134934351 countsByYear W21349343512017 @default.
• W2134934351 countsByYear W21349343512019 @default.
• W2134934351 countsByYear W21349343512020 @default.
• W2134934351 crossrefType "journal-article" @default.
• W2134934351 hasAuthorship W2134934351A5005180091 @default.
• W2134934351 hasAuthorship W2134934351A5018159030 @default.
• W2134934351 hasAuthorship W2134934351A5020699194 @default.
• W2134934351 hasAuthorship W2134934351A5045722599 @default.
• W2134934351 hasAuthorship W2134934351A5064104774 @default.
• W2134934351 hasAuthorship W2134934351A5071697628 @default.
• W2134934351 hasAuthorship W2134934351A5081124890 @default.
• W2134934351 hasAuthorship W2134934351A5085986301 @default.
• W2134934351 hasAuthorship W2134934351A5087164515 @default.
• W2134934351 hasConcept C126322002 @default.
• W2134934351 hasConcept C137183658 @default.
• W2134934351 hasConcept C142724271 @default.
• W2134934351 hasConcept C15744967 @default.
• W2134934351 hasConcept C170493617 @default.
• W2134934351 hasConcept C24998067 @default.
• W2134934351 hasConcept C2775864247 @default.
• W2134934351 hasConcept C2776992516 @default.
• W2134934351 hasConcept C2777843972 @default.
• W2134934351 hasConcept C2778581513 @default.
• W2134934351 hasConcept C2779908668 @default.
• W2134934351 hasConcept C42219234 @default.
• W2134934351 hasConcept C513476851 @default.
• W2134934351 hasConcept C548259974 @default.
• W2134934351 hasConcept C71924100 @default.
• W2134934351 hasConcept C99631742 @default.
• W2134934351 hasConceptScore W2134934351C126322002 @default.
• W2134934351 hasConceptScore W2134934351C137183658 @default.
• W2134934351 hasConceptScore W2134934351C142724271 @default.
• W2134934351 hasConceptScore W2134934351C15744967 @default.
• W2134934351 hasConceptScore W2134934351C170493617 @default.
• W2134934351 hasConceptScore W2134934351C24998067 @default.

• next